MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

MC

453.45

-2.24%↓

SANES

6.794

-2.31%↓

BNP

74.71

-2.25%↓

ALV

333.4

-1.51%↓

BBVA

12.865

-1.57%↓

Search

AB Science SA

Closed

1.14 0.18

Overview

Share price change

24h

Current

Min

1.122

Max

1.142

Key metrics

By Trading Economics

Income

-4.5M

Sales

560K

Profit margin

-798.036

Employees

28

EBITDA

-4.6M

Market Stats

By TradingEconomics

Market Cap

78M

Previous open

0.96

Previous close

1.14

Technical Score

By Trading Central

Confidence

Bearish Evidence

AB Science SA Chart

Past performance is not a reliable indicator of future results.

Related News

19 Jun 2025, 15:04 UTC

Acquisitions, Mergers, Takeovers

UniCredit's Banco BPM Bid Gets Conditional EU Nod -- Update

19 Jun 2025, 14:33 UTC

Acquisitions, Mergers, Takeovers

UniCredit's Banco BPM Bid Gets Conditional EU Nod

19 Jun 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

19 Jun 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 Jun 2025, 20:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Home Depot Bid Kicks Off a Battle for $5 Billion Building-Products Company -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Home Depot Privately Made Bid for Building-Products Distributor GMS, Sources Say -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Competing Offers Could Prompt Bidding War for GMS, Sources Say -- WSJ

19 Jun 2025, 20:38 UTC

Acquisitions, Mergers, Takeovers

Offer From Home Depot Comes as QXO Makes Unsolicited Proposal at $95.20 Per Share -- WSJ

19 Jun 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Worthington Buys Elgen Manufacturing for About $93M, Funded With Cash on Hand

19 Jun 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Says Elgen Will Become Part of Its Building Products Segment

19 Jun 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Acquires Elgen Manufacturing >WOR

19 Jun 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19 Jun 2025, 16:20 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

19 Jun 2025, 15:37 UTC

Market Talk

European Gas Soars on Middle East Escalation Fears -- Market Talk

19 Jun 2025, 15:16 UTC

Market Talk

Copper Prices Look Set to Fall Over Third Quarter, Citi Says -- Market Talk

19 Jun 2025, 15:16 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19 Jun 2025, 15:10 UTC

Market Talk

Dollar Rises as Israel-Iran Conflict Intensifies -- Market Talk

19 Jun 2025, 15:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 Jun 2025, 15:02 UTC

Market Talk

Oil Climbs 2% as Israel-Iran Tensions Mount, With U.S. Role in Focus -- Market Talk

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU: UniCredit Committed to Divest 209 Physical Branches in Overlap Areas Across Italy

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU: UniCredit Commitments Fully Address Competition Concerns Identified

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Rejected Request From Italian Competition Authority to Refer Deal for National Review

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Approves UniCredit's Acquisition of Banco BPM, Subject to Conditions

19 Jun 2025, 14:15 UTC

Acquisitions, Mergers, Takeovers

EU Says There Are No Compelling Reasons to Justify Referral to Italy

19 Jun 2025, 13:58 UTC

Market Talk

Market Talk Roundup: BOE Holds Rates as Focus Turns to Likely August Cut

19 Jun 2025, 13:58 UTC

Market Talk

Market Talk Roundup: BOE Holds Rates as Focus -2-

19 Jun 2025, 13:38 UTC

Market Talk

Canadian Small Firms Appear to Be Coping With Tariffs -- Market Talk

19 Jun 2025, 13:33 UTC

Market Talk

BOE Likely to Cut Rates If Firms' Pricing Power Weakens -- Market Talk

19 Jun 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer Comparison

Price change

AB Science SA Forecast

Technical Score

By Trading Central

1.426 / 1.448Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.